DONALD WARD: Open Payments
NPI 1154979359 · MARYVILLE, TN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,736 in 105 payments from 13 companies in 2025. Trend: 2023 $2,590 · 2024 $2,231 · 2025 $1,736
Food & beverage: $1,736
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 52 | $723 |
| Takeda Pharmaceuticals U.S.A., Inc. | 9 | $191 |
| Aimmune Therapeutics, Inc. | 7 | $161 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 13 | $143 |
| Phathom Pharmaceuticals, Inc. | 6 | $116 |
| Janssen Biotech, Inc. | 4 | $94 |
| Madrigal Pharmaceuticals | 3 | $67 |
| QOL Medical, LLC | 2 | $55 |
| Novo Nordisk Inc | 2 | $47 |
| Ardelyx, Inc. | 2 | $47 |
Products named: RINVOQ, ENTYVIO, LINZESS, ZENPEP, XIFAXAN, VOQUEZNA, TREMFYA, SKYRIZI.
Industry payments across TN — which companies pay providers there.
